Comparison of Erector Spinae Plane Block and Intravenous Analgesic in Nefrectomy

Erector Spinae Plane Block for Nefrectomy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04686890

Enrollment

Registered

2020-12-29

Start date

2020-12-30

Completion date

2021-03-10

Last updated

2021-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephrectomy, Regional Anesthesia Morbidity

Keywords

nefrectomy, erector spinea plane block

Brief summary

The efficacy of erector spinae plane block versus intravenous analgesics compared relate to the morphine consumptions

Detailed description

Patients undergoing elective nefrectomy were enrolled. Patients divided into two groups with a sealed envelope technique to ESP+ pca morphine group or iv analgesic + pca morphine group. All patients will premedicated. then esp will applied to one group before surgery at the preoperative care unit by the same anesthesiologist. The other group will receive intravenous tramadol 1 mg/kg + NSAID 1 ampule + parol 10 mg/ kg + ondansetron 4 mg bolus. İntravenous morphine pca with a concentration of 0.5 mg/cc were applied. And administered 1 mg boluses every 15 minutes lock time and 4 hour limit as 4 mg arranged. An anesthesia nurse who is responsible of all pcas' in the hospital was recorded the variables of these patients in the service

Interventions

PROCEDUREerector spinea plane block administered preoperative open nephrectomy

erector spinae plane block applied in this group before open nephrectomy

PROCEDUREintravenous analgesic ( 1 mg/kg tramadol + non-steroid antiinflamatuar paracetamol )drug + 10 mg.kg

intarvenous analgesic administered in this group for analgesia end of the open nephrectomy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

18-65 years age * ASA I-II * undergoing elective nephrectomy

Exclusion criteria

- ASA\>3 * heart disease * pregnancy * lung disease * scoliosis * bleeding disorder * infection at the manipulation side

Design outcomes

Primary

Measure	Time frame	Description
Postoperative intravenous morphine patient controlled analgesia consumption	during postoperatively	morphine consumptions were recorded till 24 th hour postoperatively
Peroperative remifentanyl consumption	Peroperatively	Amount of Remifentanyl consumption recorded

Secondary

Measure	Time frame	Description
Visual analog rating scores	during postoperative surgery	pain scores were recorded during surgery

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026